| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 9,000 | $33.93 | $305,384.50 | -7.0% | -4.5% | - | |
| Feb 2, 2026 | ALKS Alkermes Plc. | Cooke Shane62 | Director | Sell | 61,200 | $34.57 | $2,115,672.52 | -20.3% | -4.5% | - | |
| Feb 2, 2026 | PCRX Pacira Biosciences, Inc. | Williams Kristen76 | Chief Administrative Officer | Sell | 13,137 | $20.53 | $269,702.61 | -9.1% | +15.2% | - | |
| Feb 2, 2026 | PCRX Pacira Biosciences, Inc. | Riker Lauren76 | Senior Vice President, Finance | Sell | 4,000 | $20.81 | $83,240.00 | -7.1% | +15.2% | - | |
| Jan 30, 2026 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 25,000 | $0.17 | $4,365.00 | -0.6% | - | - | |
| Jan 26, 2026 | LQDA Liquidia Corp | Boyle Dana | Chief Accounting Officer | Sell | 1,580 | $41.65 | $65,807.00 | -0.9% | - | - | |
| Jan 26, 2026 | JNJ Johnson & Johnson | Duato Joaquin | CEO And Chairman Of The Board | Sell | 100,000 | $221.23 | $22,122,893.44 | -47.5% | - | - | |
| Jan 26, 2026 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 688 | $41.65 | $28,655.20 | -0.3% | - | - | |
| Jan 26, 2026 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 30,375 | $470.03 | $14,277,113.90 | -36.4% | - | - | |
| Jan 23, 2026 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 30,000 | $0.19 | $5,571.00 | -0.8% | - | - | |
| Jan 20, 2026 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 14,625 | $464.66 | $6,795,626.74 | -12.9% | - | - | |
| Jan 16, 2026 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 30,000 | $0.18 | $5,529.00 | -0.8% | - | - | |
| Jan 16, 2026 | AKAN Akanda Corp. | Hrt Financial LP | 10% Owner | Sell | 7,868 | $1.29 | $10,149.72 | -50.2% | - | - | |
| Jan 15, 2026 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 8,300 | $469.89 | $3,900,121.92 | -3.3% | +21.1% | - | |
| Jan 15, 2026 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 14,134 | $40.31 | $569,753.01 | -7.6% | +44.5% | - | |
| Jan 15, 2026 | AKAN Akanda Corp. | Hrt Financial LP | 10% Owner | Buy | 29,036 | $1.40 | $40,650.40 | -217.5% | -52.2% | - | |
| Jan 13, 2026 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 500 | $84.33 | $42,165.00 | -0.7% | -4.8% | - | |
| Jan 13, 2026 | BIOA Bioage Labs, Inc. | Fortney Kristen | Chief Executive Officer | Sell | 233,107 | $18.12 | $4,223,036.34 | -19.3% | -21.7% | - | |
| Jan 13, 2026 | BIOA Bioage Labs, Inc. | Goldstein Dov A Md | Chief Financial Officer | Sell | 27,000 | $19.70 | $531,827.69 | -18.0% | -21.7% | - | |
| Jan 12, 2026 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $479.51 | $10,788,876.00 | -100% | +18.5% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 20,533 | $37.43 | $768,550.19 | -11.7% | +5.3% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Kaseta Michael58 | CFO And COO | Sell | 36,932 | $37.43 | $1,382,364.76 | -9.5% | +5.3% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Krepp Sarah | Chief Human Resource Officer | Sell | 13,165 | $37.43 | $492,765.95 | -8.6% | +5.3% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 21,142 | $37.43 | $791,345.06 | -10.7% | +5.3% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Jeffs Roger67 | Chief Executive Officer | Sell | 66,610 | $37.43 | $2,493,212.30 | -6.0% | +5.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.